Noble Financial initiates coverage on Auxilium Pharmaceuticals (Nasdaq: AUXL) with a Buy rating. PT $42 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE